Search

Robert L. Deberadinis

Examiner (ID: 10283, Phone: (571)272-2049 , Office: P/2836 )

Most Active Art Unit
2836
Art Unit(s)
2836
Total Applications
3088
Issued Applications
2682
Pending Applications
168
Abandoned Applications
275

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20115022 [patent_doc_number] => 12364706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Modified aminoglycoside compounds and uses thereof in disabling bacterial ribosome [patent_app_type] => utility [patent_app_number] => 17/325361 [patent_app_country] => US [patent_app_date] => 2021-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 33691 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 663 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325361 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/325361
Modified aminoglycoside compounds and uses thereof in disabling bacterial ribosome May 19, 2021 Issued
Array ( [id] => 18468799 [patent_doc_number] => 20230203081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => LINCOSAMIDE ANTIBIOTICS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/926809 [patent_app_country] => US [patent_app_date] => 2021-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58391 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -84 [patent_words_short_claim] => 336 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926809 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/926809
LINCOSAMIDE ANTIBIOTICS AND USES THEREOF May 19, 2021 Pending
Array ( [id] => 18610845 [patent_doc_number] => 20230277575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => Nucleoside Analogues to Inhibit the Main Protease of a Coronavirus [patent_app_type] => utility [patent_app_number] => 17/926451 [patent_app_country] => US [patent_app_date] => 2021-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12487 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926451 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/926451
Nucleoside Analogues to Inhibit the Main Protease of a Coronavirus May 19, 2021 Abandoned
Array ( [id] => 20212597 [patent_doc_number] => 12409231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Cycloalkyne derivatized saccharides [patent_app_type] => utility [patent_app_number] => 17/320482 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 14551 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320482 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/320482
Cycloalkyne derivatized saccharides May 13, 2021 Issued
Array ( [id] => 18451627 [patent_doc_number] => 20230192906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => POLYROTAXANE HAVING GROUP THAT HAS CHAIN FORMED BY HAVING CIRCULAR MOLECULE HAVE PROPYLENEOXY REPEATING UNIT [patent_app_type] => utility [patent_app_number] => 17/998648 [patent_app_country] => US [patent_app_date] => 2021-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998648
POLYROTAXANE HAVING GROUP THAT HAS CHAIN FORMED BY HAVING CIRCULAR MOLECULE HAVE PROPYLENEOXY REPEATING UNIT May 11, 2021 Abandoned
Array ( [id] => 18434313 [patent_doc_number] => 20230181607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 17/924662 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -82 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924662 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/924662
Thiosaccharides for use in treating coronavirus infection May 10, 2021 Issued
Array ( [id] => 17168789 [patent_doc_number] => 20210322459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => PROPHYLACTIC USE OF INULIN AGAINST SINUSITIS [patent_app_type] => utility [patent_app_number] => 17/315436 [patent_app_country] => US [patent_app_date] => 2021-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4770 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315436 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/315436
Prophylactic use of inulin against sinusitis May 9, 2021 Issued
Array ( [id] => 17050652 [patent_doc_number] => 20210260086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS [patent_app_type] => utility [patent_app_number] => 17/315144 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19611 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315144 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/315144
METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS May 6, 2021 Abandoned
Array ( [id] => 18420220 [patent_doc_number] => 20230174681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => PARAMYLON-BASED RESIN, MOLDING MATERIAL, MOLDED BODY, AND PRODUCTION METHOD FOR PARAMYLON-BASED RESIN [patent_app_type] => utility [patent_app_number] => 17/923787 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16780 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923787 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923787
Paramylon-based resin, molding material, molded body, and production method for paramylon-based resin May 6, 2021 Issued
Array ( [id] => 18405798 [patent_doc_number] => 20230167149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => CD33 LIGANDS SUITABLE FOR INCORPORATION INTO CARRIERS [patent_app_type] => utility [patent_app_number] => 17/997374 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22622 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 538 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997374 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997374
CD33 LIGANDS SUITABLE FOR INCORPORATION INTO CARRIERS Apr 29, 2021 Abandoned
Array ( [id] => 18525467 [patent_doc_number] => 11712445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-01 [patent_title] => Compositions and methods for improving gastrointestinal function in subjects with renal disease [patent_app_type] => utility [patent_app_number] => 17/246433 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3204 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246433 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/246433
Compositions and methods for improving gastrointestinal function in subjects with renal disease Apr 29, 2021 Issued
Array ( [id] => 18466894 [patent_doc_number] => 20230201174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES [patent_app_type] => utility [patent_app_number] => 17/996816 [patent_app_country] => US [patent_app_date] => 2021-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996816 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996816
COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES Apr 19, 2021 Pending
Array ( [id] => 18451628 [patent_doc_number] => 20230192907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID AND HYALURONIC ACID SO OBTAINED [patent_app_type] => utility [patent_app_number] => 17/918659 [patent_app_country] => US [patent_app_date] => 2021-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4885 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918659 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/918659
PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID AND HYALURONIC ACID SO OBTAINED Apr 15, 2021 Pending
Array ( [id] => 17020987 [patent_doc_number] => 20210244858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => SOFT TISSUE FILLER COMPOSITION WITH HYALURONIC ACID AND BENZYL ALCOHOL [patent_app_type] => utility [patent_app_number] => 17/227714 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1879 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227714 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/227714
SOFT TISSUE FILLER COMPOSITION WITH HYALURONIC ACID AND BENZYL ALCOHOL Apr 11, 2021 Abandoned
Array ( [id] => 20264108 [patent_doc_number] => 12435084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-07 [patent_title] => Indazole derivatives as inhibitors of SARM1 [patent_app_type] => utility [patent_app_number] => 17/995046 [patent_app_country] => US [patent_app_date] => 2021-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25503 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995046 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995046
Indazole derivatives as inhibitors of SARM1 Apr 6, 2021 Issued
Array ( [id] => 18374353 [patent_doc_number] => 20230149432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => Human Milk Oligosaccharides for Improving Resistance of Organism Against Staphylococcus Aureus Infection [patent_app_type] => utility [patent_app_number] => 17/995228 [patent_app_country] => US [patent_app_date] => 2021-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8553 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995228 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995228
Human Milk Oligosaccharides for Improving Resistance of Organism Against Staphylococcus Aureus Infection Apr 5, 2021 Pending
Array ( [id] => 18948130 [patent_doc_number] => 11891411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-06 [patent_title] => Industrial utilization method for [patent_app_type] => utility [patent_app_number] => 17/216928 [patent_app_country] => US [patent_app_date] => 2021-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5753 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216928 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/216928
Industrial utilization method for Mar 29, 2021 Issued
Array ( [id] => 18626644 [patent_doc_number] => 20230285442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => USE OF OLIGOCHITOSANS AND DERIVATIVES THEREOF FOR NEUTRALIZING VIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 17/914225 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26433 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914225 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/914225
USE OF OLIGOCHITOSANS AND DERIVATIVES THEREOF FOR NEUTRALIZING VIRAL AGENTS Mar 25, 2021 Pending
Array ( [id] => 19246788 [patent_doc_number] => 20240197772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac [patent_app_type] => utility [patent_app_number] => 17/909854 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909854 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/909854
COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac Mar 23, 2021 Abandoned
Array ( [id] => 18312639 [patent_doc_number] => 20230116539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => Collagenase Activity Inhibitor [patent_app_type] => utility [patent_app_number] => 17/913874 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913874 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/913874
Collagenase Activity Inhibitor Mar 21, 2021 Pending
Menu